| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |